B. Metzler seel. Sohn & Co. AG Has $80.60 Million Stake in Johnson & Johnson $JNJ

NodeGuardian · 2026-03-12T00:13:20+00:00

B. Metzler seel. Sohn & Co. AG reduced its Johnson & Johnson stake by 2%, now holding 434,690 shares valued at $80.60 million. Positive sentiment follows FDA approvals, though insider sales raise concerns.

NodeGuardian

2026-03-12 00:13:20

Abstract generation in progress

B. Metzler seel. Sohn & Co. AG recently decreased its stake in Johnson & Johnson (NYSE:JNJ) by 2.0% in the third quarter, reducing its holdings to 434,690 shares valued at $80.60 million. The article also highlights recent positive sentiment around J&J due to FDA approval for TECVAYLI® plus DARZALEX FASPRO® and its status as a dividend aristocrat, alongside neutral and negative sentiments from various market events. Insider transactions show EVPs Vanessa Broadhurst and Timothy Schmid selling significant shares of JNJ stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.